Michael Jorgensen

Dr. Michael Jorgensen

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in The Journal of the American Dental Association
Verified
Journal Article
Closed access
MJMichael Jorgensen
Michael Jorgensen
WCWilliam B. Carroll
William B. Carroll

30 April 2003 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
THT. Hoang
T. Hoang
MJMichael Jorgensen
Michael Jorgensen
RKR. G. Keim
R. G. Keim
APA. M. Pattison
A. M. Pattison
JSJ. Slots
J. Slots

13 September 2002 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
NDNazanin Daneshmand
Nazanin Daneshmand
MJMichael Jorgensen
Michael Jorgensen
HNHessam Nowzari
Hessam Nowzari
JMJohn L. Morrison
John L. Morrison
JSJørgen Slots
Jørgen Slots

1 November 2001 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
HNHessam Nowzari
Hessam Nowzari
MJMichael Jorgensen
Michael Jorgensen
TTThai T. Ta
Thai T. Ta
ACAdolfo Contreras
Adolfo Contreras
JSJ⊘Rgen Slots
J⊘Rgen Slots
Background: Fanconi's anemia is an autosomal recessive disease associated with chromosomal breakage as well as pancytopenia, skin pigmentation, renal hypoplasia, cardiac defects, microcephaly, congenital malformations of the skeleton, hypogonadism, and increased risk of leukemia. The present report describes the periodontal clinical and microbiological status of an 11‐year old male having Fanconi's anemia.Methods: Polymerase chain reaction analysis to detect human cytomegalovirus (HCMV), Epstein‐Barr type 1 virus, and herpes simplex virus (HSV) was performed on paper‐point samples pooled from either 3 periodontal sites with advanced attachment loss or 3 gingivitis sites with no clinical attachment loss. Anaerobic bacterial culture examination was performed on the pooled periodontitis sample.Results: The patient suffered from pancytopenia, allergy, asthma, hearing impairment, and mental retardation. Dentition consisted of 7 primary teeth, 11 erupted permanent teeth, and 14 unerrupted permanent teeth. Most erupted teeth showed severe gingival inflammation with some gingival overgrowth and various degrees of periodontal attachment loss. Genomes of HCMV and HSV were detected in the pooled periodontitis sample and HCMV in the pooled gingivitis sample. The periodontitis sample but not the gingivitis sample revealed HCMV mRNA of major capsid protein, suggestive of active viral infection. The periodontitis sample also yielded Actinobacillus actinomycetemcomitans (1.1% of total isolates), Fusobacterium species (7.9%), Campylobacter species (2.2%), Peptostreptococcus micros (3.4%), and Candida albicans (0.3%).Conclusions: Oral features of Fanconi's anemia may include increased susceptibility to periodontitis. It is likely that underlying host defense impairment coupled with periodontal infection by HCMV and A. actinomycetemcomitans contribute to the severe type of periodontitis associated with Fanconi's anemia. J Periodontol 2001;72:1601‐1606.

1 September 1999 in Journal of Periodontology
Verified
Journal Article
Closed access
NZNiloofar Zarkesh
Niloofar Zarkesh
HNHessam Nowzari
Hessam Nowzari
JMJohn L. Morrison
John L. Morrison
MJMichael Jorgensen
Michael Jorgensen
Periodontal pathogens are detrimental to periodontal healing in barrier membrane-assisted periodontal therapy. Tetracycline-coating of barrier membranes may reduce levels of infecting pathogens. This study evaluated the clinical and microbiological effects of tetracycline-coated expanded polytetrafluoroethylene (T-ePTFE) barrier membranes in the treatment of 2- to 3-wall intraosseous periodontal lesions around mandibular molars. Eleven patients received non-coated barrier membranes (ePTFE) and 11 patients received T-ePTFE barrier membranes. Tetracycline coating was performed by placing ePTFE membranes first in a 5% tridodecylmethylammonium chloride solution and then in a basic 3% tetracycline solution. Microbiological examination included conventional culture and DNA probe analyses. Barrier membranes were removed 6 weeks after insertion. At baseline, the periodontal lesion depth averaged 8.0 mm in the ePTFE treated group and 7.4 mm in the T-ePTFE group. At 1 year post-treatment, the mean gain of probing attachment was 1.9 mm in the ePTFE group and 3.3 mm in the T-ePTFE group (P = 0.02). At 3 minutes after membrane placement, suspected periodontal pathogens were detected in several ePTFE membranes but only in one T-ePTFE membrane. At 6 weeks, all membranes showed periodontal pathogens, including Porphyromonas gingivalis, Fusobacterium species, Peptostreptococcus micros, Bacteroides forsythus, and motile rods. This study suggests that the use of tetracycline-coated ePTFE barrier membranes can result in additional gain of clinical periodontal attachment, most likely due to the antimicrobial properties of tetracycline during initial healing.

1 August 2005 in International Dental Journal
Verified
Journal Article
Closed access
PDF file
MJMichael Jorgensen
Michael Jorgensen
AAAlexandre Aalam
Alexandre Aalam
JSJørgen Slots
Jørgen Slots